Growth Metrics

Merck (MRK) Gross Profit Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.23%
Dec 31, 2025 12.88%
Sep 30, 2025 11.14%
Jun 30, 2025 13.14%
Mar 31, 2025 6.73%
Dec 31, 2024 35.57%
Sep 30, 2024 8.39%
Jun 30, 2024 8.15%
Mar 31, 2024 9.52%
Dec 31, 2023 6.81%
Sep 30, 2023 10.27%
Jun 30, 2023 9.33%
Mar 31, 2023 9.03%
Dec 31, 2022 7.31%
Sep 30, 2022 9.45%
Jun 30, 2022 8.78%
Mar 31, 2022 10.50%
Dec 31, 2021 7.74%
Sep 30, 2021 6.37%
Jun 30, 2021 5.78%
Mar 31, 2021 5.29%
Dec 31, 2020 -1.44%
Sep 30, 2020 4.63%
Jun 30, 2020 1.84%
Mar 31, 2020 8.35%
Dec 31, 2019 -17.48%
Sep 30, 2019 5.83%
Jun 30, 2019 6.71%
Mar 31, 2019 4.07%
Dec 31, 2018 2.81%
Sep 30, 2018 0.70%
Jun 30, 2018 0.94%
Mar 31, 2018 0.42%
Dec 31, 2017 -1.59%
Sep 30, 2017 -0.92%
Jun 30, 2017 -3.63%
Mar 31, 2017 -3.66%
Dec 31, 2016 -3.93%
Sep 30, 2016 -1.46%
Jun 30, 2016 -4.45%
Mar 31, 2016 -5.26%
Dec 31, 2015 -3.62%
Sep 30, 2015 -1.86%
Jun 30, 2015 -2.36%
Mar 31, 2015 -1.15%
Dec 31, 2014 5.33%
Sep 30, 2014 6.52%
Jun 30, 2014 5.85%
Mar 31, 2014 9.44%